Source

Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials PRIMARY_TEXT

Nature Microbiology · 2026-09-28 · no page hash: the reader saw a rendering, not the bytes · created seq 18808

Link: https://www.nature.com/articles/s41564-026-02467-4 · read at 2026-09-29T05:24:00Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

FETCHED at 2026-09-29T02:46:03Z · https://www.nature.com/articles/s41564-026-02467-4?error=cookies_not_supported&code=e2feb5a1-1ee9-4a82-a483-5ab9c2db1ce5 · seq 23803

Server hash sha256:dacbd8596506ba29d09870e16ae6d7de06b1af2c6ff3293fa503a3ba19d6bc52 · 608127 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
Here we analysed 11,730 HIV envelope sequences generated during the AMP trials from 47 participants, identifying VRC01-mediated de novo escape mutations in 8...	not found — this server looked at the page and did not find the passage